☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Lambert-Eaton Myasthenic Syndrome
Jacobus Pharmaceutical's Ruzurgi (amifampridine) Receives the US FDA's Approval for Lambert-Eaton myasthenic syndrome
May 6, 2019
Catalyst's Firdapse (amifampridine) Receives FDA's Approval for Lambert-Eaton Myasthenic Syndrome
October 20, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.